Showing 27,061 - 27,080 results of 105,386 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( e ((fold decrease) OR (point decrease)) ))', query time: 0.98s Refine Results
  1. 27061
  2. 27062

    Image_5_T cell receptor β repertoires in patients with COVID-19 reveal disease severity signatures.pdf by Jing Xu (15337)

    Published 2023
    “…We specifically focused on SARS-CoV-2-associated TCR clonotypes.</p>Results<p>We observed a decrease in the diversity of TCR clonotypes in COVID-19 patients compared to healthy controls. …”
  3. 27063
  4. 27064
  5. 27065
  6. 27066

    Data_Sheet_5_The Value of Expanding the Training Population to Improve Genomic Selection Models in Tetraploid Potato.XLSX by Elsa Sverrisdóttir (5600327)

    Published 2018
    “…<p>Genomic selection (GS) is becoming increasingly applicable to crops as the genotyping costs continue to decrease, which makes it an attractive alternative to traditional selective breeding based on observed phenotypes. …”
  7. 27067
  8. 27068
  9. 27069

    The effects of thioperamide and alpha-FMH on the amount of sleep/wake in WT and W/W<sup>v</sup> mice. by Sachiko Chikahisa (417256)

    Published 2013
    “…<p>(A) Injection of thioperamide (ip), a H3 antagonist, at a high dose (10 mg/kg) increased wakefulness in both WT and W/W<sup>v</sup> mice for 3 hours. …”
  10. 27070

    The effects of TDBP-TAZTO (5 and 50 mg/kg) on spatial learning and memory in rats in the Morris water test. by Liang Ye (6646)

    Published 2015
    “…Data ate expressed as mean ± SE (n = 10/group). <sup>a</sup><i>p</i> < 0.05, TDBP-TAZTO 5 mg/kg group vs. control group; <sup>b</sup><i>p</i> < 0.05, TDBP-TAZTO 50 mg/kg group vs. control group.…”
  11. 27071

    HSE suppressed the binding activities of STAT5b to the IGF-1R and STAT3 to the VEGF promoter sites. by Jin Hee Park (153335)

    Published 2012
    “…Data represent means of at least three separate experiments. Asterisks indicate a statistically significant decrease by t-test (***p<0.001) in the crosstalks of STAT5b/IGF-1R and STAT3/VEGF respectively.…”
  12. 27072

    Effects of α-syn expression on 20/26S proteasomal activity in living SH-SY5Y cells. by Lisa Zondler (3405464)

    Published 2017
    “…<p>A cellular 20/26S proteasome assay implementing SH-SY5Y cells that stably express wild-type or A53T α-syn as well as a mock control was performed to assess the effect of the presence of α-syn on proteasomal activity on a neuronal background. …”
  13. 27073

    Seroepidemiological investigation of HAdV-4 infection among healthy adults in China and in Sierra Leone, West Africa by Busen Wang (6536051)

    Published 2019
    “…In addition, the seropositive rates of both HAdV-4 and HAdV-5 nAbs increased with age. However, the nAbs stimulated by HAdV-4 remained stable at low (≤200) levels among the different age groups, whereas moderate (201–1000) or high (>1000) nAb levels were produced by HAdV-5 and tended to decrease with age. …”
  14. 27074

    Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients by Baoqing Sun (558067)

    Published 2023
    “…<p>The emerging COVID-19 caused by SARS-CoV-2 infection poses severe challenges to global public health. …”
  15. 27075
  16. 27076
  17. 27077

    Presenting symptoms. by Tamrat Petros Elias (18536434)

    Published 2024
    “…Finally, 340 were included in the study. The majority (68.5%) were males and the mean age was 53.9 (±13.3 SD) years. …”
  18. 27078

    Comorbidity pattern of patients. by Tamrat Petros Elias (18536434)

    Published 2024
    “…Finally, 340 were included in the study. The majority (68.5%) were males and the mean age was 53.9 (±13.3 SD) years. …”
  19. 27079

    Patient selection for this study. by Tamrat Petros Elias (18536434)

    Published 2024
    “…Finally, 340 were included in the study. The majority (68.5%) were males and the mean age was 53.9 (±13.3 SD) years. …”
  20. 27080

    Characteristics of treatment modality. by Adekunle Emmanuel Sajo (15285520)

    Published 2025
    “…The median time to completion of radiotherapy treatment was higher among those who received primary radiotherapy as compared to those who received adjuvant treatment, 51.5 vs 46 days, p 0.039. The annual average age decreased from 56 years to as low as 40 years, a mean difference of 16 years, p 0.012.…”